JPWO2021145296A1 - - Google Patents

Info

Publication number
JPWO2021145296A1
JPWO2021145296A1 JP2021571178A JP2021571178A JPWO2021145296A1 JP WO2021145296 A1 JPWO2021145296 A1 JP WO2021145296A1 JP 2021571178 A JP2021571178 A JP 2021571178A JP 2021571178 A JP2021571178 A JP 2021571178A JP WO2021145296 A1 JPWO2021145296 A1 JP WO2021145296A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021571178A
Other languages
Japanese (ja)
Other versions
JP7397886B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021145296A1 publication Critical patent/JPWO2021145296A1/ja
Application granted granted Critical
Publication of JP7397886B2 publication Critical patent/JP7397886B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Jellies, Jams, And Syrups (AREA)
JP2021571178A 2020-01-14 2021-01-12 セルロース誘導体を基剤とする機械的強度および酸素透過性が改善された硬カプセル Active JP7397886B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP20151712 2020-01-14
JPPCT/JP2020/000827 2020-01-14
EP20151712.5 2020-01-14
JP2020000827 2020-01-14
JP2020029007 2020-07-29
JPPCT/JP2020/029007 2020-07-29
PCT/JP2021/000605 WO2021145296A1 (ja) 2020-01-14 2021-01-12 セルロース誘導体を基剤とする機械的強度および酸素透過性が改善された硬カプセル

Publications (2)

Publication Number Publication Date
JPWO2021145296A1 true JPWO2021145296A1 (https=) 2021-07-22
JP7397886B2 JP7397886B2 (ja) 2023-12-13

Family

ID=76863766

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021571178A Active JP7397886B2 (ja) 2020-01-14 2021-01-12 セルロース誘導体を基剤とする機械的強度および酸素透過性が改善された硬カプセル

Country Status (2)

Country Link
JP (1) JP7397886B2 (https=)
WO (1) WO2021145296A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024143343A1 (ja) * 2022-12-27 2024-07-04 クオリカプス株式会社 遮光剤を含む皮膜からなる硬質カプセル、硬質カプセル調製液、及び硬質カプセルの調製方法
WO2026053962A1 (ja) * 2024-09-06 2026-03-12 キャプシュゲル・ベルジウム・エヌ・ヴィ 酸化チタンを含まず硫酸ナトリウムを含む遮光性皮膜

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1927186A (zh) * 2006-08-26 2007-03-14 青岛大学 一种植物源硬胶囊壳的配方及其制备方法
CN101439028A (zh) * 2009-01-06 2009-05-27 湖州展望天明药业有限公司 羟丙甲纤维素组合物及其在制备植物基药用胶囊中的应用
EP2179728A1 (en) * 2007-08-10 2010-04-28 Shanghai Huiyuan Vegetal Capsule Co., Ltd Non-gelatin shell material of hard capsule and process for preparing thereof
US20100113620A1 (en) * 2007-03-29 2010-05-06 Aston University Enteric pharmaceutical capsules
CN106265592A (zh) * 2016-09-30 2017-01-04 山东赫尔希胶囊有限公司 羟丙甲纤维素空心硬胶囊及其制备方法
WO2020009142A1 (ja) * 2018-07-04 2020-01-09 キャプシュゲル・ベルジウム・エヌ・ヴィ 白色化剤として界面活性剤又は界面活性剤と塩を含有する皮膜形成性組成物

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1927186A (zh) * 2006-08-26 2007-03-14 青岛大学 一种植物源硬胶囊壳的配方及其制备方法
US20100113620A1 (en) * 2007-03-29 2010-05-06 Aston University Enteric pharmaceutical capsules
EP2179728A1 (en) * 2007-08-10 2010-04-28 Shanghai Huiyuan Vegetal Capsule Co., Ltd Non-gelatin shell material of hard capsule and process for preparing thereof
CN101439028A (zh) * 2009-01-06 2009-05-27 湖州展望天明药业有限公司 羟丙甲纤维素组合物及其在制备植物基药用胶囊中的应用
CN106265592A (zh) * 2016-09-30 2017-01-04 山东赫尔希胶囊有限公司 羟丙甲纤维素空心硬胶囊及其制备方法
WO2020009142A1 (ja) * 2018-07-04 2020-01-09 キャプシュゲル・ベルジウム・エヌ・ヴィ 白色化剤として界面活性剤又は界面活性剤と塩を含有する皮膜形成性組成物

Also Published As

Publication number Publication date
WO2021145296A1 (ja) 2021-07-22
JP7397886B2 (ja) 2023-12-13

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220722

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230801

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231101

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20231121

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231201

R150 Certificate of patent or registration of utility model

Ref document number: 7397886

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150